Importantly, these results also demonstrate the functionality of expanded CD8+ T cells (cytotoxicity and IFN-γ secretion), reinforcing the interest in targeting the immune response toward these immunogenic peptides in HCC patients. The gene discussed is CD8A; the disease is hepatocellular carcinoma.